Objective-Plaque rupture may be the local expression of a widespread coronary instability. This study aimed to investigate:
C oronary plaque rupture with subsequent thrombosis is the most common substrate of acute coronary syndrome and sudden cardiac death. [1] [2] [3] [4] Although this phenomenon is often considered to result from a local instability, many of the pathophysiological factors believed to trigger plaque rupture (eg, inflammation or mechanical stress modulated by sympathetic tone) exert a widespread effect within the coronary tree. 5, 6 In a seminal coronary angiography study, Goldstein et al 7 found that a substantial proportion of patients (≈40%) presenting with acute myocardial infarction (AMI) harbors multiple complex coronary lesions, which are related to adverse clinical outcomes. Subsequent intravascular ultrasound investigations yielded variable results, with a prevalence of plaque rupture at sites remote from the culprit lesion ranging from 14% to 79% in patients with acute presentations. [8] [9] [10] [11] Interestingly, some of these studies suggested that additional plaque ruptures may occur even in stable or asymptomatic patients. 9, 10 Using coronary angioscopy, Asakura et al 12 observed the diffuse presence of yellow plaques in patients with recent AMI, although the detection of thrombus distant from the culprit lesion was relatively rare. However, the imaging techniques used in these studies were limited in their spatial resolution and were not the modalities of choice for detecting and characterizing plaque rupture. 13 Therefore, the exact incidence and morphological features of plaque rupture at sites remote from the culprit lesion remain unknown. In addition, the clinical background and pancoronary atherosclerotic phenotype of patients experiencing multiple plaque ruptures have not been fully characterized, and it remains unclear whether multiple plaque ruptures occur simultaneously as the result of a generalized acute plaque destabilization. Optical coherence tomography (OCT) is a novel intracoronary imaging modality with high spatial resolution (≈10-15 μm), which enables detailed in vivo characterization of atherosclerotic plaques 14 and readily identifies plaque ruptures undetected by other imaging tools, such as intravascular ultrasound or angioscopy. 13 In the present study, through OCT analysis of all the 3 major epicardial vessels in patients with AMI, unstable angina pectoris (UAP), or stable angina pectoris (SAP), we aimed to: (1) assess the prevalence and morphological characteristics of nonculprit plaque rupture; (2) compare the overall (pancoronary) plaque phenotype between patients with and without nonculprit plaque rupture; and (3) determine prevalence, morphological, and clinical predictors of multiple plaque ruptures.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Prevalence of Nonculprit Plaque Rupture
Six hundred and seventy-five nonculprit lesions were identified in 261 patients (Figure 1 ). Plaque rupture was detected in 71 nonculprit lesions from 51 patients (20%). A representative OCT image of plaque rupture is shown in Figure 2 . Baseline patient characteristics are reported in Table 1 . Patients with nonculprit plaque rupture tended to be more frequently men and current smokers and to have higher levels of serum creatinine and total cholesterol, with significantly greater levels of LDL-cholesterol. Angiographic findings of all analyzed plaques are summarized in Table I in the online-only Data  Supplement. Compared with lesions without plaque rupture,  those with plaque rupture had larger reference diameter, lon- ger length, and greater diameter stenosis and were more frequently located in the right coronary artery.
The prevalence of nonculprit plaque rupture in patients with AMI, UAP, and SAP was 24% (8/34 patients), 12% (9/73 patients), and 22% (34/154 patients), respectively (P=0.184). Out of 71 nonculprit plaque ruptures identified, overlying thrombus was detected in 21 (32%) and was more frequently observed in patients with AMI (9/12 [75%] nonculprit plaques) compared with those with UAP (4/12 [33%] nonculprit plaques) and SAP (10/47 [21%] nonculprit plaques; P=0.001; Figure 3 ). On the basis of the clinical presentation, nonculprit plaque rupture distribution was the following: 12 nonculprit plaque ruptures were detected in patients with AMI (out of 82 nonculprit plaques), 12 in patients with UAP (out of 193 nonculprit plaques), and 47 in patients with SAP (out of 400 nonculprit plaques). Overall, 17 (24%) nonculprit plaque ruptures were located in the culprit vessel and 54 (76%) in the nonculprit vessels. At the time of index OCT imaging, 9 out of 71 (13%) lesions with nonculprit plaque ruptures were treated with PCI. Pre-PCI OCT imaging of the culprit lesion was performed in 114 patients: 21 out of 34 (61.8%) patients with AMI, 31 out of 73 (42.5%) patients with UAP, and 62 out of 154 (40.3%) patients with SAP. Among 114 culprit lesions imaged, 36 (32%) showed plaque rupture, which was significantly more frequent in patients with AMI (14/21, 67%) than in those with UAP (10/31, 32%) and SAP (12/62, 19%; P<0.001). In these patients, the overall prevalence of multiple plaque ruptures (ie, culprit plaque rupture plus ≥1 nonculprit plaque rupture or multiple nonculprit plaque ruptures) was 20%, being significantly higher in patients with AMI (8/21, 38%) than UAP (3/31, 10%) and SAP (12/62, 19%; P=0.042). Patients with plaque rupture at the culprit lesion showed more frequent nonculprit plaque rupture compared with those without plaque rupture at the culprit site (44.4% versus 15.4%; P<0.001). In this subpopulation, culprit vessel was left anterior descending coronary artery in 52 patients, left circumflex in 21 patients, and right coronary artery in 41 patients. The mean total length of analyzed OCT pullbacks was 220±48 mm (93±26 mm in the right coronary artery, 73±24 mm in the left anterior descending artery, and 54±18 mm in the left circumflex). There was no difference in the length of the analyzed segments between patients with and patients without nonculprit plaque rupture (222±50 versus 219±48 mm; P=0.414). Intra-and interobserver agreements for plaque rupture were k=0.92 and k=0.81, respectively.
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Morphological Characteristics of Nonculprit Plaque Rupture
The morphological characteristics of nonculprit plaque ruptures, as compared with those at culprit sites, are presented in Figure 4 . at the center of the plaque; nonculprit plaque ruptures occurred less frequently at the shoulders compared with culprit plaque ruptures (33.9% versus 55.9%; P=0.038). There was no difference in the prevalence of macrophage accumulation (P=0.451) or intimal vasculature (P=0.231) between the 2 groups.
In patients with pre-PCI imaging of the culprit lesion, ROC analysis was implemented to identify the cutoff values of OCT plaque features that best discriminated between culprit and nonculprit plaque ruptures ( Table II in the online-only Data  Supplement) . Specifically, minimum lumen area <1.51 mm 2 (area under the curve [AUC]=0.834; P<0.001), minimum FCT <57 μm (AUC=0.749; P<0.001), cavity length >1.9 mm (AUC=0.730; P<0.001), maximum cavity area >0.68 mm 2 (AUC=0.719; P<0.001), and lipid index >1562 (AUC=0.673; P=0.004) represented the best cutoff values for discriminating culprit from nonculprit plaque ruptures. After backward, stepwise, multivariate logistic regression analysis, minimum lumen area <1.51 mm 2 (odds ratio: 0.55; 95% confidence interval: 0.38−0.81; P=0.002), minimum FCT <57 μm (odds ratio: 0.97; 95% confidence interval: 0.95−0.99; P=0.029), and cavity length >1.9 mm (odds ratio: 2.90; 95% confidence interval: 1.52−5.52; P=0.001) constituted the best combination of findings for discriminating culprit from nonculprit plaque rupture.
Pancoronary Plaque Phenotype in Patients With and Without Nonculprit Plaque Rupture
Qualitative and quantitative OCT analyses were performed on all the nonculprit plaques (n=675) within the 3 major epicardial coronary arteries, and the results were compared between patients with and without nonculprit plaque rupture ( Table 2 ; Table III in the online-only Data Supplement). Both patient-based (Table 2 ) and plaque-based analysis ( Table III in the online-only Data Supplement) showed significantly higher prevalence of fibroatheromas and TCFA in the coronary vasculature of patients with nonculprit plaque rupture. Intimal vasculature, macrophage accumulation, cholesterol crystal, calcification, and thrombus were also more frequent in patients with nonculprit plaque rupture. In addition, all the quantitative measures of lipid burden (ie, mean lipid arc, lipid length, and lipid index) were greater, whereas the fibrous cap was thinner ( Table III in 
Predictors of Multiple Plaque Ruptures
In the subgroup of 114 patients who received pre-PCI imaging of the culprit lesion, the overall (pancoronary) nonculprit plaque characteristics were compared among patients with multiple, single, and no plaque rupture. Patients with multiple plaque ruptures showed the highest prevalence of TCFA, as compared with those with single and no plaque rupture, on both patient-based (A) and plaque-based (B) analyses ( Figure 5 ). All other differences in OCT plaque characteristics among patients with multiple, single, and no plaque rupture are summarized in Tables IV and V in the online-only Data Supplement.
Univariate logistic regression analysis showed that TCFA, intimal vasculature, and macrophage accumulation at nonculprit sites were associated with the presence of multiple plaque ruptures ( Table VI in the online-only Data Supplement) . Similarly, presentation with AMI, current smoking, and chronic kidney disease (defined as an estimated glomerular filtration rate <60 mL/min/1.73 m 2 ) represented the clinical findings associated with the presence of multiple plaque ruptures (Tables VII in the online-only Data Supplement) . At multivariate analysis, TCFA, intimal vasculature, and macrophage accumulation at nonculprit sites remained independent morphological predictors of multiple plaque ruptures, whereas presentation with AMI and chronic kidney disease constituted the independent clinical predictors ( Figure 6 ).
Clinical Follow-Up
Clinical follow-up was obtained in 256 patients (98.1%). Mean follow-up time was 12.4±1.6 months (12.3±1.4 months in patients with nonculprit plaque rupture and 12.4±1.7 in those without; P=0.879). Table 3 summarizes the clinical outcomes in patients with versus without nonculprit plaque rupture. Over 1-year follow-up, 16 patients (6.3%) developed clinical adverse events, including 1 cardiac death (0.4%), 2 nonfatal AMI (0.8%), and 15 nontarget lesion revascularization (TLR; 5.9%). The mean time from the index procedure to clinical adverse events was 251±89 days. Non-TLR was considered as clinical adverse events only when they occurred outside of the window period corresponding to the index admission. None of the non-TLR was staged PCI. The mean time from the index procedure to non-TLR was 263±69 days. Out of 15 non-TLR, 2 were urgent PCI (1 ST-segment-elevation myocardial infarction and 1 non-ST-segment-elevation myocardial infarction) and 13 were elective PCI. The overall incidence of clinical adverse events tended to be higher in patients with nonculprit plaque rupture than in those without ( Figure 7 ).
Discussion
The present study provides in vivo evidence of the widespread nature of plaque rupture in patients with coronary artery disease undergoing 3-vessel OCT imaging. The main findings were the following: (1) nonculprit plaque rupture was detected in ≈1 in 5 patients, even in those with stable symptoms; (2) nonculprit plaque ruptures showed overlying thrombus in most patients with AMI, but only in a minority of patients with UAP or SAP; (3) compared with the culprit plaque ruptures, nonculprit plaque ruptures exhibited smaller cavity area and length, thicker fibrous cap, and larger minimum lumen area; (4) patients with nonculprit plaque rupture had a pancoronary high-risk atherosclerotic phenotype, as evidenced by a significantly higher prevalence of TCFA at nonculprit sites; (5) the presence of multiple plaque ruptures was observed in 20% of patients and was associated with the presence of TCFA, intimal vasculature, and macrophage accumulation, as well as with AMI and chronic kidney disease; (6) patients with nonculprit plaque rupture tended to have worse outcome after 1 year, primarily driven by higher rates of non-TLR.
Widespread Nature of Coronary Plaque Rupture
The intriguing idea of the widespread nature of coronary plaque rupture originates from pathological studies showing the presence of several disrupted plaques in the coronaries of subjects dying from ischemic heart disease, 15, 16 as well as in subjects dying from noncardiac causes. 17 Using coronary Data are presented as absolute number (%) or median (interquartile range). In patient-based analysis, data on prevalence are for one or more such OCT features per patient. FCT indicates fibrous cap thickness; OCT, optical coherence tomography; and TCFA, thin-cap fibroatheroma. and plaque-based (B) analyses showed that patients with multiple plaque ruptures had significantly higher prevalence of TCFA within the coronary vasculature than those with single or no plaque rupture.
angiography, Goldstein et al 7 observed multiple complex coronary stenoses in ≈40% of patients presenting with AMI, suggesting multiple simultaneous plaque ruptures. Coronary angiography, however, lacks sensitivity and specificity for the detection of plaque rupture. Previous intravascular ultrasound studies have reported frequencies of nonculprit plaque rupture varying from 14% to 79% of patients with acute coronary syndrome. [8] [9] [10] [11] In our study, we found at least one nonculprit plaque rupture in 20% of patients. The prevalence of nonculprit plaque rupture was higher in patients with SAP (22%) than in those with UAP (12%). However, nonculprit plaque ruptures were less frequently covered by thrombus in patients with SAP (21%) than in those with UAP (33%). We speculate that a greater proportion of nonculprit plaque ruptures in patients with SAP were actually old, silent plaque ruptures as compared with those with UAP, which may be more frequently the expression of an acute plaque destabilization. This finding suggests that even stable or asymptomatic patients may experience episodes of plaque instability, which remain clinically silent, substantiating the observations from pathology series reporting the presence of plaque rupture in 9% of healthy subjects and in 22% of asymptomatic patients with diabetes mellitus or hypertension who died suddenly. 17 However, it is possible that differences in thrombus coverage of nonculprit plaque rupture among groups of patients with different clinical presentations may be related to the different prescription rates of antithrombotic therapies. In a subset of patients who also had pre-PCI imaging of the culprit lesion, the incidence of multiple plaque ruptures (either at both culprit and nonculprit sites or at multiple nonculprit sites) was 20% and was significantly higher in patients with AMI (38%). Similarly intriguing, we observed that the majority of nonculprit plaque ruptures in patients with AMI were covered by thrombus (ie, 75%), compared with only a minority of those in patients with UAP or SAP. This finding supports the concept that patients presenting with AMI may be subject to a generalized acute destabilization of plaques with increased systemic hypercoagulability. Nonculprit plaque ruptures were observed not only in the culprit vessel but also in the nonculprit ones, endorsing the widespread nature of their occurrence. In our study, C-reactive protein levels were not significantly different between patients with and those without nonculprit plaque rupture. Previous imaging studies suggested that higher levels of C-reactive protein may be present in patients with plaque rupture at the nonculprit lesions. 18 However, these observations were limited by the small sample size and were not obtained from 3-vessel imaging data. These observations were not confirmed by a subanalysis from the PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) trial, which is the largest 3-vessel imaging study ever performed, where C-reactive protein levels were not significantly different between patients with and without nonculprit plaque rupture. 11 A plausible explanation for the absence of correlation between high C-reactive protein levels and the presence of nonculprit plaque rupture may be that, in addition to the diffuse nature of inflammation, other potential factors might trigger disruption of nonculprit plaques, such as increase in the blood pressure-derived tensile stress within the culprit vessel during an acute coronary event or enhanced mechanical stress modulated by the sympathetic tone. 5,19 Figure 6 . Independent predictors of multiple plaque ruptures. At multivariate analysis, thin-cap fibroatheroma (TCFA), intimal vasculature, and macrophage accumulation at nonculprit sites were independent morphological predictors of multiple plaque ruptures, whereas presentation with acute myocardial infarction (AMI) and chronic kidney disease were independent clinical predictors. 
Distinctive Features of Nonculprit Plaque Rupture
The factors that determine the fate of an unstable plaque toward either silent progression or clinical manifestation remain elusive. 20 Our data showed that nonculprit plaque ruptures have typical morphological features, which discriminate them from culprit plaque ruptures. Compared with the culprit plaque ruptures, those at nonculprit sites had lower lipid burden, thicker fibrous cap, and larger lumen.
Pancoronary High-Risk Atherosclerotic Phenotype in Patients With Nonculprit Plaque Rupture
Our results demonstrated that patients with nonculprit plaque rupture have a diffuse, pancoronary vulnerable phenotype. At least one TCFA was detected in the coronary tree of approximately half of patients with nonculprit plaque rupture, and the rate was even higher (≈70%) in patients with multiple plaque ruptures. In addition, the prevalence of intimal vasculature and macrophage accumulation was significantly greater in the coronary arteries of these patients. These results are in line with the report by Uemura et al 21 identifying TCFA and intimal vasculature at nonculprit regions as predictors of angiographic plaque progression, which may indeed happen through silent episodes of disruption and healing of such plaques. 17 Similarly, TCFA was the highest-risk plaque phenotype associated with major adverse cardiac events in the PROSPECT study. 22
Morphological and Clinical Predictors of Multiple Plaque Ruptures
In our study, TCFA, intimal vasculature, and macrophage accumulation at nonculprit sites were independent predictors of multiple plaque ruptures ( Figure 6 ). This finding underscores the importance of TCFA as substrate for plaque rupture and supports the potential role of intimal vasculature and inflammation in widespread plaque destabilization. Although TCFA represented an independent predictor of multiple plaque rupture in our study, only one quarter of all the nonculprit plaques in patients with multiple plaque ruptures, and 11% of those in patients with single plaque rupture were TCFA. Overall, patients with multiple plaque rupture had thinner FCT It may be possible that the relatively low prevalence of TCFA was related to the definition itself (ie, lipid-rich plaque with a fibrous cap thinner than 65 µm), although our definition of TCFA was the same proposed by the Consensus OCT documents 23, 24 and widely used in previous OCT studies. 25, 26 Independent clinical predictors of multiple plaque ruptures were presentation with AMI and chronic kidney disease ( Figure 6 ). Enhanced inflammatory activity, surges in sympathetic activity, and local mechanical and hemodynamic stress may be potential mechanisms linking AMI with the presence of multiple plaque ruptures. 6, 18, 19 Chronic kidney disease is a recognized risk factor for future coronary events and is associated with a 3-fold increase in cardiovascular mortality. 27 Recent studies suggest that patients with chronic kidney disease have more features of advanced atherosclerotic disease, including a larger necrotic core and a higher prevalence of calcifications. 28 A predisposition to develop multiple plaque ruptures may represent the missing link between advanced atherosclerosis and higher cardiovascular risk in patients with chronic kidney disease.
Clinical Follow-Up
During 1-year follow-up, 1 patient (2.0%) with nonculprit plaque rupture suffered nonfatal AMI and 6 (11.8%) underwent non-TLR. The incidence of non-TLR was higher in patients with nonculprit plaque rupture than in those without. Several angiography studies reported that complex lesions are at higher risk for rapid stenosis progression 29 and need for repeat catheterization. 7 A subanalysis of the PROSPECT study identified a tendency for nonculprit lesions with intravascular ultrasound-defined plaque rupture to result in higher rates of nonculprit major adverse cardiac events (because of a trend toward more rehospitalizations for unstable or progressive angina), although the incidence of overall clinical adverse events was not different between patients with and without nonculprit plaque rupture. 11 In our study, the highest 1-year rate of clinical adverse events was observed in patients with both nonculprit plaque rupture and TCFA (Figure 7) , suggesting that both morphological substrate and the patient's tendency to plaque instability are important determinants of adverse clinical outcome. Patients with such morphological substrate might represent the ideal candidates for a strategy of a complete revascularization as proposed by the PRAMI and CVLPRIT trials, 30, 31 although this hypothesis needs to be tested in large clinical studies. Although the present study represents, to the best of our knowledge, the largest 3-vessel OCT investigation to date, the relatively small patient population and observed event rates limit the power of the study to predict future events, and therefore, our data on clinical outcome should be considered as hypothesis generating.
Limitations
The present study has several limitations. First, as a retrospective observational study from a multicenter registry, potential selection bias cannot be excluded. In addition, the sample size is relatively small, although this represents the largest 3-vessel OCT study performed to date. Including only patients with 3-vessel OCT imaging may have introduced some selection bias, as it might be possible that the operator's decision to image all the 3 major epicardial vessels was dictated by the presence of stenotic or complex lesions also in the nonculprit vessels. On the contrary, absence of suitable coronary anatomy (eg, excessive vessel tortuosity, severe vessel calcification) or unfavorable clinical conditions (eg, severe kidney disease, congestive heart failure, hemodynamic or electric instability, etc) might have prevented the performance of 3-vessel OCT imaging in some patients. This represents another potential source of selection bias. However, the use of 3-vessel imaging minimized the bias related to a single-vessel imaging, enabling a comprehensive assessment of the coronary morphology, which was crucial for the purpose of this study. Second, although all 3 major epicardial coronary arteries were interrogated by OCT, some imaging pullbacks did not include the distal or ostial vessel segments. Third, pre-PCI OCT imaging of the culprit lesion was not performed in all the patients. Fourth, in patients with SAP with multiple lesions requiring stenting (13.0%), the most severely stenotic lesion was labeled as the culprit lesion. However, a functional assessment of coronary stenosis, such as fractional flow reserve, would have been more appropriate in these cases. Fifth, only lesions with area stenosis >50% were included in the analysis. This may have impacted on the estimates of prevalence of nonculprit plaque rupture in our study. Sixth, both FD-OCT and TD-OCT systems were used in the present study. Because of the lower resolution and quality of TD-OCT images, potential misinterpretation or underestimation of plaque features cannot be excluded. Seventh, the FCT measurement may be limited by the subjectivity of visual identification of the thinnest point and manual measurement. 32 In the future, automated image processing and quantification algorithms of OCT images 33, 34 may enhance the accuracy of these OCT measurements. Eighth, although the interobserver agreement for the detection of nonculprit plaque rupture was good (k=0.81), it needs to be interpreted with caution as the prevalence of plaque rupture at the nonculprit sites was relatively low (ie, 20%). Ninth, the number of clinical adverse events was relatively small in the present study, and variations in medical management of patients may account for differences in clinical outcome. Therefore, this results need to be considered as hypothesis generating. Tenth, macrophage accumulation was defined qualitatively as the presence of bright spots within the fibrous cap with backward shadowing. However, emerging evidences suggest that bright spots can be observed in areas characterized by rapid changes in the index of refraction, such as collagen-rich fibrous tissue, cholesterol clefts, or interfaces between calcium and surrounding tissue. 35 These results need therefore to be interpreted with caution. Finally, because of attenuation of the OCT light signal by red blood cells, the presence of thrombus may have influenced the characterization of underlying plaque in some cases.
Conclusions
Nonculprit plaque ruptures were observed in 20% of patients with coronary artery disease undergoing cardiac catheterization, even in stable patients. These plaques were widespread throughout the coronary circulation and were frequently covered by thrombus in patients with AMI, endorsing the possibility of a multifocal acute plaque destabilization in these patients. Nonculprit plaque ruptures showed distinctive morphological features, including smaller cavity dimensions, thicker fibrous cap, and less severe lumen narrowing compared with culprit plaque ruptures. Multiple plaque ruptures were detected in 20% of patients, particularly in those with AMI, and could be predicted on the bases of morphological and clinical findings. Patients with nonculprit plaque rupture exhibited a pancoronary high-risk atherosclerotic phenotype, including higher prevalence of TCFA, and showed higher revascularization rates after 1 year. 
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